(VIANEWS) - STAAR Surgical Company (STAA), MDU Resources Group (MDU), Edwards Lifesciences (EW) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. STAAR Surgical Company (STAA)
31.6% sales growth and 11.87% return on equity
STAAR Surgical Company and its subsidiaries design, manufacture, market, sell, and distribute implantable lenses for eyes, as well as companion delivery systems, to get the lenses in the eye.
STAAR Surgical Company's sales growth this year is expected to be 28.1% and 27.1% for next year.
Year-on-year quarterly revenue growth grew by 24.5%, now sitting on 242.92M for the twelve trailing months.
Volume
Today's last reported volume for STAAR Surgical Company is 375425 which is 34.49% below its average volume of 573084.
STAAR Surgical Company's sales growth is a negative 0% for the present quarter and 31.6% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 5.9% and 8.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.87%.
Volatility
STAAR Surgical Company's last day, last week, and last month's current intraday variation average was 4.07%, 4.11%, and 4.39%, respectively.
STAAR Surgical Company's highest amplitude of average volatility was 4.11% (day), 4.98% (last week), and 6.58% (last month), respectively.
STAAR Surgical Company's Stock Yearly Top and Bottom Value
STAAR Surgical Company's stock is valued at $67.01 at 11:22 EST, way below its 52-week high of $163.08 and way above its 52-week low of $49.03.
STAAR Surgical Company's Moving Average
STAAR Surgical Company's value is above its 50-day moving average of $63.77 and way below its 200-day moving average of $91.04.2. MDU Resources Group (MDU)
24.7% sales growth and 11.06% return on equity
MDU Resources Group, Inc. is involved in US-regulated energy delivery, construction materials, and service businesses.
MDU Resources Group's sales growth this year is anticipated to be 7.9% and 2.9% for next year.
Year-on-year quarterly revenue growth grew by 15.4%, now sitting on 5.87B for the twelve trailing months.
Volume
Today's last reported volume for MDU Resources Group is 887100 which is 47.77% below its average volume of 1698750.
MDU Resources Group's sales growth is a negative 0% for the ongoing quarter and 24.7% for the next. The company's growth estimates for the ongoing quarter and the next is 4% and 14.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.06%.
Volatility
MDU Resources Group's last day, last week, and last month's current intraday variation average was 0.37%, 0.78%, and 1.13%, respectively.
MDU Resources Group's highest amplitude of average volatility was 0.99% (day), 1.70% (last week), and 2.31% (last month), respectively.
MDU Resources Group's Stock Yearly Top and Bottom Value
MDU Resources Group's stock is valued at $27.37 at 11:22 EST, way below its 52-week high of $34.00 and above its 52-week low of $24.92.
MDU Resources Group's Moving Average
MDU Resources Group's worth is higher than its 50-day moving average of $26.61 and below its 200-day moving average of $28.66.3. Edwards Lifesciences (EW)
10.6% sales growth and 29.3% return on equity
Edwards Lifesciences Corporation offers products and technology for critical care, surgical monitoring and structural heart disease in the United States as well as internationally.
Edwards Lifesciences's sales growth this year is expected to be 9.5% and 12% for next year.
Year-on-year quarterly revenue growth grew by 10.2%, now sitting on 5.36B for the twelve trailing months.
Volume
Today's last reported volume for Edwards Lifesciences is 979132 which is 65.92% below its average volume of 2873360.
Edwards Lifesciences's sales growth for the next quarter is 10.6%. The company's growth estimates for the ongoing quarter and the next is a negative 0% and 18.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 29.3%.
Volatility
Edwards Lifesciences's last day, last week, and last month's current intraday variation average was 1.20%, 2.39%, and 2.22%, respectively.
Edwards Lifesciences's highest amplitude of average volatility was 2.63% (day), 3.16% (last week), and 3.21% (last month), respectively.
Edwards Lifesciences's Stock Yearly Top and Bottom Value
Edwards Lifesciences's stock is valued at $88.46 at 11:22 EST, under its 52-week low of $91.34.